Vir Biotechnology (VIR) Stock Insights

VIR price $11.93 +0.36 +3.11%

Ticker
VIR
Price
$11.93
Change
+0.36 +3.11%
Market cap ?
$2.02B
P/E ?
-5.64
Dividend yield ?
0.00%
Beta ?
1.59
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
64
Value
46
Quality
46
Growth
100

Stocklytics score rationale: value 46, quality 46, growth 100.

Financials

201720182019202020212022202320242025
27080001066800080909997636800010954150001615797000861800007420500068556000

Vir Biotechnology, Inc. operates as an immunology company with commercialized products, dedicated to devising therapeutic solutions for the treatment and prevention of significant infectious diseases. Its pipeline features several key candidates: Sotrovimab (branded as Xevudy, or VIR-7832), a neutralizing monoclonal antibody for both treating and preventing SARS-CoV-2 infection; VIR-2218 and VIR-3434, aimed at…

Fair value

VIR fair value $98.10. Price $11.93. Price is 88% below fair value.

Below fair value, but more expensive than usual. A smaller discount than on 82% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare VIR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.74—858.88K
2026-08-050.470.33238.95M135.88M
2026-05-06-0.85-0.01-29.00K55.49M
2026-02-23-0.31-0.4264.07M19.91M
2025-11-05-1.17-0.70240.00K19.91M
2025-08-06-0.80-0.721.21M2.72M
2025-05-07-0.88-0.831.79M8.59M
2025-02-26-0.76-0.8512.37M8.14M
2024-10-31-1.56-0.962.38M9.37M
2024-08-01-1.02-0.933.08M7.50M
2024-05-02-0.48-0.9956.38M11.71M
2024-02-22-0.86-1.1416.79M13.43M
2023-11-02-1.22-1.214.10M10.24M
2023-08-03-1.45-1.2112.72M25.89M
2023-05-04-1.06-0.8146.71M50.10M
2023-02-23-0.76-0.3921.79M149.61M
2022-11-031.30-0.21371.43M114.22M
2022-08-09-0.58-0.1742.69M200.72M
2022-05-053.853.781.23B811.05M
2022-02-243.923.04809.76M622.96M
2021-11-040.820.02102.71M105.13M
2021-08-050.46-0.48173.99M84.56M
2021-05-06-1.32-0.23605.00K7.62M
2021-02-25-0.83-0.72301.00K62.19K
2020-11-10-0.67-0.57188.00K1.70M
2020-08-11-0.27-0.6266.27M153.82M
2020-05-12-0.71-0.48487.00K4.27M
2020-03-26-0.71-0.47371.00K951.59K
2019-11-19-4.60-3.71237.00K1.13M
2019-10-10-0.31—86.00K—
2019-03-31-0.30—17.00K—
2018-12-31-0.27—6.00K—
2018-09-30-0.35—114.00K—
2018-06-30-4.02—2.33M—
2018-03-31-4.02—2.33M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-27Topalian Suzanne LouiseBuy9.46K$11.57109.48K
2026-10-27Topalian Suzanne LouiseBuy16.00K$11.57185.12K
2026-10-27Topalian Suzanne LouiseBuy4.73K——
2026-10-27Topalian Suzanne LouiseBuy8.00K——
2026-10-27Topalian Suzanne LouiseOther0——
2026-10-05Sawaf AzizOther0——
2026-08-11MORE ROBERT JBuy8.00K——
2026-08-11MORE ROBERT JSell8.00K——
2026-06-09Coughlin TimothyBuy8.00K——
2026-06-09Coughlin TimothyBuy16.00K$8.51136.16K
2026-06-09Coughlin TimothyBuy8.00K——
2026-06-09Coughlin TimothyOther0——
2026-06-01Napolitano JanetSell3.20K$9.4530.24K
2026-06-01Sabatini BrentSell379$9.453.58K
2026-05-27Sigal Charles ElliottBuy8.00K——
2026-05-27Sigal Charles ElliottBuy16.00K$9.10145.60K
2026-05-27Napolitano JanetBuy8.00K——
2026-05-27Napolitano JanetBuy16.00K$9.10145.60K
2026-05-27MORE ROBERT JBuy8.00K——
2026-05-27MORE ROBERT JBuy16.00K$9.10145.60K
2026-05-27Hatfield Jeffrey S.Buy8.00K——
2026-05-27Hatfield Jeffrey S.Buy16.00K$9.10145.60K
2026-05-27Farid RamyBuy8.00K——
2026-05-27Farid RamyBuy16.00K$9.10145.60K
2026-05-27BISCHOFBERGER NORBERT WBuy8.00K——
2026-05-27BISCHOFBERGER NORBERT WBuy16.00K$9.10145.60K
2026-05-01SATO VICKI LSell22.00K$10.05221.03K
2026-04-29De Backer MarianneSell233.53K——
2026-04-29De Backer MarianneBuy233.53K——
2026-04-06De Backer MarianneSell72.56K$9.16664.35K
2026-04-01SATO VICKI LSell22.00K$9.07199.62K
2026-03-23Sabatini BrentSell7.71K$9.1270.32K
2026-03-20O'Byrne JasonSell2.50K——
2026-03-20O'Byrne JasonBuy2.50K——
2026-03-02SATO VICKI LSell21.80K$9.50207.19K
2026-03-02SATO VICKI LSell200$9.982.00K
2026-02-25Eisner MarkSell1.89K$9.8218.55K
2026-02-25de Verneuil VaninaSell13.70K$9.82134.53K
2026-02-24SATO VICKI LBuy42.38K$1.4962.93K
2026-02-24SATO VICKI LSell42.18K$9.75411.31K
2026-02-24SATO VICKI LSell200$10.262.05K
2026-02-24SATO VICKI LSell42.38K$1.4962.93K
2026-02-24Sabatini BrentSell1.43K$9.5313.63K
2026-02-24O'Byrne JasonSell1.63K$9.5315.58K
2026-02-24Eisner MarkSell1.62K$9.5315.40K
2026-02-24de Verneuil VaninaSell3.12K$9.5329.71K
2026-02-24De Backer MarianneSell14.76K$9.53140.72K
2026-02-23Sabatini BrentSell1.83K$7.4513.63K
2026-02-23O'Byrne JasonSell2.09K$7.4515.57K
2026-02-23Eisner MarkSell2.09K$7.4515.57K
2026-02-23de Verneuil VaninaSell4.45K$7.4533.13K
2026-02-23De Backer MarianneSell19.04K$7.45141.89K
2026-02-22Sabatini BrentBuy25.00K——
2026-02-22Sabatini BrentBuy50.00K$7.56378.00K
2026-02-22O'Byrne JasonBuy55.00K——
2026-02-22O'Byrne JasonBuy110.00K$7.56831.60K
2026-02-22Eisner MarkBuy55.00K——
2026-02-22Eisner MarkBuy110.00K$7.56831.60K
2026-02-22de Verneuil VaninaBuy55.00K——
2026-02-22de Verneuil VaninaBuy110.00K$7.56831.60K
2026-02-22De Backer MarianneBuy285.00K——
2026-02-22De Backer MarianneBuy570.00K$7.564.31M
2026-02-13Sabatini BrentSell1.53K$7.7911.92K
2026-02-02SATO VICKI LSell22.00K$7.71169.67K
2026-01-02SATO VICKI LSell22.00K$5.93130.38K
2025-12-01SVF Endurance (Cayman) LtdSell191.85K$5.981.15M
2025-12-01SATO VICKI LSell22.00K$6.00132.07K
2025-11-28SVF Endurance (Cayman) LtdSell61.49K$6.44396.01K
2025-11-26SVF Endurance (Cayman) LtdSell127.94K$6.39817.65K
2025-11-25SVF Endurance (Cayman) LtdSell235.97K$6.381.51M
2025-11-24SVF Endurance (Cayman) LtdSell227.80K$6.151.40M
2025-11-17O'Byrne JasonSell6.80K$5.5637.78K
2025-11-05de Verneuil VaninaSell2.38K$5.1612.31K
2025-11-03de Verneuil VaninaSell1.36K$5.868.00K
2025-11-03SATO VICKI LSell22.00K$5.64124.05K
2025-10-29SVF Endurance (Cayman) LtdSell100$6.49649
2025-10-28SVF Endurance (Cayman) LtdSell24.45K$6.50159.01K
2025-10-27SVF Endurance (Cayman) LtdSell66.40K$6.05401.59K
2025-10-24SVF Endurance (Cayman) LtdSell46.70K$5.96278.28K
2025-10-23SVF Endurance (Cayman) LtdSell154.38K$5.99924.72K
2025-10-22SVF Endurance (Cayman) LtdSell144.27K$6.15887.65K
2025-10-21SVF Endurance (Cayman) LtdSell109.67K$6.30690.97K
2025-10-20SVF Endurance (Cayman) LtdSell220.53K$6.201.37M
2025-10-16SVF Endurance (Cayman) LtdSell12.84K$6.1078.37K
2025-10-15SVF Endurance (Cayman) LtdSell16.67K$6.07101.20K
2025-10-10SVF Endurance (Cayman) LtdSell2.30K$6.0813.97K
2025-10-09SVF Endurance (Cayman) LtdSell249.06K$6.141.53M
2025-10-08SVF Endurance (Cayman) LtdSell466.24K$6.052.82M
2025-10-07SVF Endurance (Cayman) LtdSell72.13K$5.60404.15K
2025-10-06SVF Endurance (Cayman) LtdSell73.95K$5.69420.64K
2025-10-03SVF Endurance (Cayman) LtdSell450.34K$5.562.50M
2025-10-01SATO VICKI LSell22.00K$5.84128.40K
2025-09-02SATO VICKI LSell22.00K$4.99109.81K
2025-08-01SATO VICKI LSell22.00K$4.99109.70K
2025-07-17Eisner MarkSell3.59K$5.4719.63K
2025-07-15Eisner MarkSell6.80K$5.4737.16K
2025-07-01SATO VICKI LSell22.00K$5.10112.21K
2025-06-09MORE ROBERT JBuy14.03K——
2025-06-09MORE ROBERT JSell14.03K——
2025-06-06BISCHOFBERGER NORBERT WSell10.67K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 246, holders -17 vs prior quarter. Ownership 88.20%.

HolderSharesChangeChange %Value
BLACKROCK, INC.20.68M2.68M+14.89%210.71M
ARCH VENTURE MANAGEMENT, LLC12.69M-222.50K-1.72%129.35M
VANGUARD PORTFOLIO MANAGEMENT LLC11.50M2.28M+24.74%117.14M
SB INVESTMENT ADVISERS (UK) LTD10.95M00.00%111.56M
STATE STREET CORP9.96M2.82M+39.53%101.53M
GSK PLC8.55M00.00%87.13M
VANGUARD CAPITAL MANAGEMENT LLC6.39M1.01M+18.70%65.10M
POINT72 ASSET MANAGEMENT, L.P.5.67M3.71M+190.27%57.74M
GEODE CAPITAL MANAGEMENT, LLC3.35M690.52K+25.98%34.12M
DIMENSIONAL FUND ADVISORS LP3.12M539.74K+20.92%31.79M
ADAR1 CAPITAL MANAGEMENT, LLC2.46M-288.04K-10.49%25.03M
GOLDMAN SACHS GROUP INC2.37M-885.01K-27.23%24.10M
FMR LLC2.32M246.45K+11.89%23.62M
MORGAN STANLEY2.21M-643.13K-22.53%22.53M
NUVEEN, LLC1.98M963.98K+94.60%20.21M
PICTET ASSET MANAGEMENT HOLDING SA1.95M472.49K+31.91%19.90M
BOXER CAPITAL MANAGEMENT, LLC1.87M00.00%19.01M
NORTHERN TRUST CORP1.43M446.73K+45.33%14.59M
HUDSON BAY CAPITAL MANAGEMENT LP1.36M-105.51K-7.18%13.90M
GORDONMD GLOBAL INVESTMENTS LP1.35M-165.00K-10.87%13.79M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.32M151.50K+12.93%13.48M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.32M1.32MNew13.48M
BANK OF AMERICA CORP /DE/1.14M176.72K+18.30%11.64M
TWO SIGMA INVESTMENTS, LP1.11M-329.27K-22.87%11.31M
SIO CAPITAL MANAGEMENT, LLC1.08M-423.35K-28.25%10.96M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Vir Biotechnology (VIR) Stock Insights

VIR$11.93+0.36 +3.11%

$2.02B

Market Cap

-5.64

P/E

—

Forward P/E

64

Score

Price History